[MAYBANK] QoQ Annualized Quarter Result on 30-Jun-2021 [#2]

Announcement Date
26-Aug-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Jun-2021 [#2]
Profit Trend
QoQ- -8.98%
YoY- 45.57%
View:
Show?
Annualized Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 47,628,804 45,959,390 46,269,170 47,110,818 48,870,292 51,030,965 51,692,142 -5.31%
PBT 11,889,300 10,886,595 10,888,536 11,795,110 12,686,012 8,656,956 8,886,434 21.44%
Tax -3,542,948 -2,565,080 -2,623,312 -2,873,260 -2,974,480 -1,937,877 -2,115,582 41.06%
NP 8,346,352 8,321,515 8,265,224 8,921,850 9,711,532 6,719,079 6,770,852 14.98%
-
NP to SH 8,179,572 8,096,229 8,052,477 8,709,312 9,568,520 6,481,219 6,591,752 15.48%
-
Tax Rate 29.80% 23.56% 24.09% 24.36% 23.45% 22.39% 23.81% -
Total Cost 39,282,452 37,637,875 38,003,946 38,188,968 39,158,760 44,311,886 44,921,290 -8.56%
-
Net Worth 83,815,975 85,785,748 83,885,667 82,869,597 83,826,660 84,436,116 83,289,500 0.42%
Dividend
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Div - 6,887,464 4,365,512 6,443,981 - 5,845,508 2,023,445 -
Div Payout % - 85.07% 54.21% 73.99% - 90.19% 30.70% -
Equity
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Net Worth 83,815,975 85,785,748 83,885,667 82,869,597 83,826,660 84,436,116 83,289,500 0.42%
NOSH 11,878,513 11,878,513 11,693,337 11,693,337 11,413,994 11,241,361 11,241,361 3.74%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 17.52% 18.11% 17.86% 18.94% 19.87% 13.17% 13.10% -
ROE 9.76% 9.44% 9.60% 10.51% 11.41% 7.68% 7.91% -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 400.97 387.03 395.69 409.41 428.16 453.96 459.84 -8.73%
EPS 68.88 69.66 69.79 76.00 83.84 57.66 58.64 11.33%
DPS 0.00 58.00 37.33 56.00 0.00 52.00 18.00 -
NAPS 7.0561 7.2241 7.1738 7.2016 7.3442 7.5112 7.4092 -3.20%
Adjusted Per Share Value based on latest NOSH - 11,693,337
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
RPS 394.70 380.87 383.44 390.41 404.99 422.90 428.38 -5.31%
EPS 67.78 67.09 66.73 72.17 79.30 53.71 54.63 15.47%
DPS 0.00 57.08 36.18 53.40 0.00 48.44 16.77 -
NAPS 6.9459 7.1091 6.9517 6.8675 6.9468 6.9973 6.9023 0.42%
Price Multiplier on Financial Quarter End Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 -
Price 8.94 8.30 8.05 8.11 8.25 8.46 7.22 -
P/RPS 2.23 2.14 2.03 1.98 1.93 1.86 1.57 26.38%
P/EPS 12.98 12.17 11.69 10.72 9.84 14.67 12.31 3.59%
EY 7.70 8.21 8.55 9.33 10.16 6.82 8.12 -3.48%
DY 0.00 6.99 4.64 6.91 0.00 6.15 2.49 -
P/NAPS 1.27 1.15 1.12 1.13 1.12 1.13 0.97 19.69%
Price Multiplier on Announcement Date
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Date 26/05/22 24/02/22 25/11/21 26/08/21 27/05/21 25/02/21 27/11/20 -
Price 8.98 8.64 8.11 8.39 8.39 8.09 8.33 -
P/RPS 2.24 2.23 2.05 2.05 1.96 1.78 1.81 15.28%
P/EPS 13.04 12.67 11.78 11.09 10.01 14.03 14.21 -5.57%
EY 7.67 7.89 8.49 9.02 9.99 7.13 7.04 5.88%
DY 0.00 6.71 4.60 6.67 0.00 6.43 2.16 -
P/NAPS 1.27 1.20 1.13 1.17 1.14 1.08 1.12 8.74%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment